Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
101BHG-D01 nasal spray for cold-related rhinorrhea
CTR20222611Phase 2Completed
- Sponsor
- Beijing Shuobai Pharmaceutical Technology
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 101BHG-D01 in Viral Upper Respiratory Infection, post-nasal drip (PND), sponsored by Beijing Shuobai Pharmaceutical Technology. Started Oct 2022; status: completed.
02
Drugs
101BHG-D01
03
Conditions
Viral Upper Respiratory Infectionpost-nasal drip (PND)
Beyond the preview
Go deeper on CTR20222611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222611.